• Technology
    • HemoBeads
    • HemoSystem
    • Congresses & Publications
  • Applications
    • Combination gene therapy
    • Sepsis therapy
    • Bioseparation & Processing
  • About us
    • Company
    • Team
    • Working at hemotune
    • Newsroom
    • Quality
  • Contact
  • Investors
Search
  • Home
  • Technology
    • HemoBeads
    • HemoSystem
    • Congresses & Publications
  • Applications
    • Combination gene therapy
    • Sepsis therapy
    • Bioseparation & Processing
  • About us
    • Company
    • Team
    • Working at hemotune
    • Newsroom
    • Quality
  • Contact
  • Investors
  1. hemotune
  2. About us
  3. Newsroom

Newsroom

hemotune AG appoints Harald Casebourne Stock as President of the Board of Directors

Company
8. April 2025

EN ISO 13485 Certification Expansion

Company
26. February 2025

hemotune raises CHF 14 million Series B2 funding for clinical trials with the HemoSystem

Company
25. March 2024

hemotune is a pioneering magnetic nanoparticle platform redefining precision blood purification.

LinkedIn YouTube

Technology

  • HemoBeads
  • HemoSystem
  • Congresses & Publications

Applications

  • Combination gene therapy
  • Sepsis therapy
  • Bioseparation & Processing

About us

  • Company
  • Team
  • Careers
  • Quality

Contact

hemotune AG
Wagistrasse 27
8952 Schlieren
Switzerland

info@hemotune.ch
© 2026 hemotune AG
  • Imprint
  • Data Privacy
  • Privacy Settings